Selumetinib
CAS 606143-52-6
Overview
Selumetinib was originally developed as a treatment for cancers like melanoma, pancreatic cancer, colorectal cancer, and non-small cell lung
Anant Labs manufacture and furnish high quality Selumetinib impurities for global markets. Our Selumetinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.





![Chemical structure of Methyl 4-fluoro-1-methyl-5-(methylamino)-1H-benzo[d]imidazole-6-carboxylate](/molecules/ANT-SLT-003.png)